Patent · US Expired

Inhibitors of prenyl-protein transferase

US6376496B1 · kind B1 · utility

6Cited by
6References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2000
Grant dateApr 23, 2002
Priority date
Expiry dateMar 1, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention comprises piperazine-containing compounds which inhibit prenyl-protein transferases, including farnesyl-protein transferase and geranylgeranyl-protein transferase type I. Such therapeutic compounds are useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.